Cutaneous and Systemic Adverse Effect of Topical Corticosteroid Misuse on Iraqi Women
DOI:
https://doi.org/10.31351/vol33iss3pp195-208Abstract
Topical corticosteroids (TCS) are the most widely prescribed and abused topical medications worldwide. TCs have melanogenic, anti-pruritic, atrophogenic, immunosuppressive effects on the epidermis and sex-hormone-like, in addition to anti-inflammatory activity. Several of these, if used without judgment, may have serious local and systemic negative repercussions. The current study was designed to evaluate the possible local and systemic effects of topical corticosteroid misuse among women in Basrah City and Amara city, Iraq. Totally 125 participants were categorized into three major groups: control individuals, patients who utilize TCs for 1–3 months, and patients with long-term TC use for more than 3 months. A questionnaire was filled out, and a full skin examination was performed by a special dermatologist. Blood was drawn for hematological, hormonal, and biochemical analysis. TCS abuse was linked to the development of skin conditions with various percentages and frequencies, such as erythema, photosensitivity, dryness, acne, atrophy, infections, pigmentation, hirsutism, and rosacea. TCs also have systemic adverse effects in addition to their cutaneous ones, especially with prolonged use. TCS prolongs bleeding time compared to control group. Long-term TCS suppresses ACTH and decreases cortisol concentrations significantly while having no effect on insulin or testosterone levels. Interestingly, TCS significantly reduced serum vitamin D and serum interleukin 6 compared to the normal control group. TCS misuse is a big disaster in Iraq, associated with huge skin impacts and systemic deterioration, including hormonal and hematological consequences that require medical intervention and educational and legal approaches for successful treatment.
Received 20/7/2023
Accepted 11/10/2023
Published 15/9/2024
How to Cite
Publication Dates
References
Lu H, Xiao T, Lu B, Dong D, Yu D, Wei H, et al. Facial corticosteroid addictive dermatitis in Guiyang City, China. Clinical and experimental dermatology. 2010;35(6):618-21.
Mahar S, Mahajan K, Agarwal S, Kar HK, Bhattacharya SK. Topical corticosteroid misuse: The scenario in patients attending a tertiary care hospital in New Delhi. Journal of clinical and diagnostic research: JCDR. 2016;10(12):FC16.
Sheth NK, Nair PA. Topical steroids: Awareness and misuse among patients, pharmacists and general medical practitioner. Indian Journal of Dermatology, Venereology and Leprology. 2021;87(1):54-9.
Vandevyver S, Dejager L, Tuckermann J, Libert C. New insights into the anti-inflammatory mechanisms of glucocorticoids: an emerging role for glucocorticoid-receptor-mediated transactivation. Endocrinology. 2013;154(3):993-1007.
Saraswat A, Lahiri K, Chatterjee M, Barua S, Coondoo A, Mittal A, et al. Topical corticosteroid abuse on the face: A prospective, multicenter study of dermatology outpatients. Indian journal of dermatology, venereology and leprology. 2011;77:160.
Ference JD, Last AR. Choosing topical corticosteroids. American family physician. 2009;79(2):135-40.
Kwatra G, Mukhopadhyay S. Topical corticosteroids: pharmacology. A Treatise on Topical Corticosteroids in Dermatology: Use, Misuse and Abuse. 2018:11-22.
Alotaibi SH, Alotaibi SS, Omayrah AMB, Alhusayni MI, Alshammari NM, AlAli HS, et al. Dermatological diseases: patients Awareness and concerns about complications of topical corticosteroids in Saudi Arabia. Age.15:15-25.
Ghosh A, Sengupta S, Coondoo A, Jana AK. Topical corticosteroid addiction and phobia. Indian journal of dermatology. 2014;59(5):465.
Sheary B. Steroid withdrawal effects following long-term topical corticosteroid use. Dermatitis. 2018;29(4):213-8.
Abed AS, Hassan JK. Abuse of Topical Glucocorticoids among Patients Visiting Community Pharmacy in Basrah-Iraq. Indian Journal of Forensic Medicine & Toxicology. 2021;15(4):623-32.
Jaccob AA, Yaqoub AA, Rahmani MA. Impact of abuse of topical corticosteroids and counterfeit cosmetic products for the face: prospective demographic study in basrah city, Iraq. Current Drug Safety. 2020;15(1):25-31.
Green BB, Anderson ML, Cook AJ, Catz S, Fishman PA, McClure JB, et al. Using body mass index data in the electronic health record to calculate cardiovascular risk. American journal of preventive medicine. 2012;42(4):342-7.
Agarwal P, Sahu S. Determination of hand and palm area as a ratio of body surface area in Indian population. Indian Journal of Plastic Surgery. 2010;43(01):049-53.
Chohan SN, Suhail M, Salman S, Bajwa UM, Saeed M, Kausar S, et al. Facial abuse of topical steroids and fairness creams: a clinical study of 200 patients. Journal of Pakistan Association of Dermatologists. 2014;24(3):204-11.
Rathi SK, D’Souza P. Abuse of topical corticosteroid as cosmetic cream: a social background of steroid dermatitis. A Treatise on Topical Corticosteroids in Dermatology: Use, Misuse and Abuse. 2018:129-35.
Shakeel S, Nesar S, Iffat W, Rehman H, Aziz S, Mumtaz T, et al. Pharmacists’ Insights and Behaviors in Preventing the Misuse of Topical Corticosteroids in Pakistan: A Mixed-Method Study. Cosmetics. 2021;8(3):72.
Rathi SK, Kumrah L. Topical corticosteroid-induced rosacea-like dermatitis: A clinical study of 110 cases. Indian journal of dermatology, venereology and leprology. 2011;77:42.
Al-Samman DK, Al-Banna IM, Al-Shakarchy WN, Attar-bashi MM. The Effect of Misuse of Topical Corticosteroids on Skin. Iraqi Journal of Pharmacy. 2019;14(1):63-75.
Al Dhalimi M, Al Jawahiry N. Misuse of topical corticosteroids: a clinical study in an Iraqi hospital. EMHJ-Eastern Mediterranean Health Journal, 12 (6), 847-852, 2006. 2006.
Meena S, Gupta LK, Khare AK, Balai M, Mittal A, Mehta S, et al. Topical corticosteroids abuse: A clinical study of cutaneous adverse effects. Indian journal of dermatology. 2017;62(6):675.
Kang MJ, Park JH, Park S, Kim NG, Kim EY, Yu YM, et al. Community pharmacists’ knowledge, perceptions, and practices about topical corticosteroid counseling: A real-world cross-sectional survey and focus group discussions in Korea. PLoS One. 2020;15(7):e0236797.
Abraham A, Roga G. Topical steroid-damaged skin. Indian journal of dermatology. 2014;59(5):456.
Nyati A, Singhal AK, Yadav D, Sharma MK. Topical steroid abuse on face: A prospective study from a tertiary care centre of north India. Int J Res Dermatol. 2017;3:433-8.
Karekar SR, Marathe PA, Nagarajan VB, Khopkar US, Chikhalkar SB, Desai PK, et al. Use of topical steroids in dermatology: a questionnaire based study. Indian Dermatology Online Journal. 2020;11(5):725.
Hengge UR, Ruzicka T, Schwartz RA, Cork MJ. Adverse effects of topical glucocorticosteroids. Journal of the American Academy of Dermatology. 2006;54(1):1-15.
Kakkar S, Sharma PK. Topical steroid-dependent face: Response to xylometazoline topical. Indian Journal of Drugs in Dermatology. 2017;3(2):87.
Pal D, Biswas P, Das S, De A, Sharma N, Ansari A. Topical steroid damaged/dependent face (TSDF): A study from a tertiary care hospital in Eastern India. Indian journal of dermatology. 2018;63(5):375.
Bhat YJ, Manzoor S, Qayoom S. Steroid-induced rosacea: a clinical study of 200 patients. Indian journal of dermatology. 2011;56(1):30.
Ghosh A, Coondoo A. Systemic side effects of topical corticosteroids. A Treatise on Topical Corticosteroids in Dermatology: Use, Misuse and Abuse. 2018:241-9.
McKay L, Cidlowski J. Physiologic and pharmacologic effects of corticosteroids. Holland-Frei cancer medicine. 2003;6.
Ballin A, Waisbourd‐Zinman O, Saab H, Yacobovich J, Zoldan M, Barzilai‐Birenbaum S, et al. Steroid therapy may be effective in augmenting hemoglobin levels during hemolytic crises in children with hereditary spherocytosis. Pediatric blood & cancer. 2011;57(2):303-5.
Larsen MK, Kofod T, Duch K, Starch-Jensen T. Short-term Haematological Parameters Following Surgical Removal of Mandibular Third Molars with Different Doses of Methylprednisolone Compared with Placebo. A Randomized Controlled Trial. Journal of oral & maxillofacial research. 2020;11(2).
Czarnetzki C, Elia N, Lysakowski C, Dumont L, Landis BN, Giger R, et al. Dexamethasone and risk of nausea and vomiting and postoperative bleeding after tonsillectomy in children: a randomized trial. Jama. 2008;300(22):2621-30.
Tashkin DP, Murray HE, Skeans M, Murray RP, Group LHSR. Skin manifestations of inhaled corticosteroids in COPD patients: results from Lung Health Study II. Chest. 2004;126(4):1123-33.
Bellis J, Pirmohamed M, Nunn A, Loke Y, De S, Golder S, et al. Dexamethasone and haemorrhage risk in paediatric tonsillectomy: a systematic review and meta-analysis. British journal of anaesthesia. 2014;113(1):23-42.
Coelho MCA, Santos CV, Neto LV, Gadelha MR. Adverse effects of glucocorticoids: coagulopathy. European Journal of Endocrinology. 2015;173(4):M11-M21.
Yao T-C, Huang Y-W, Chang S-M, Tsai S-Y, Wu AC, Tsai H-J. Association between oral corticosteroid bursts and severe adverse events: a nationwide population-based cohort study. Annals of internal medicine. 2020;173(5):325-30.
Majoor C, Sneeboer M, De Kievit A, Meijers J, van der Poll T, Lutter R, et al. The influence of corticosteroids on hemostasis in healthy subjects. Journal of Thrombosis and Haemostasis. 2016;14(4):716-23.
Sitter B, Johnsson MK, Halgunset J, Bathen TF. Metabolic changes in psoriatic skin under topical corticosteroid treatment. BMC dermatology. 2013;13(1):1-7.
Gomez EC, Frost P. Induction of glycosuria and hyperglycemia by topical corticosteroid therapy. Archives of Dermatology. 1976;112(11):1559-62.
Kahara T, Tanaka Y, Hayashi K, Taniguchi C, Shima KR, Usuda R, et al. Overt diabetes mellitus caused by the topical administration of dexamethasone ointment on the oral mucosa. Internal Medicine. 2014;53(15):1633-5.
Hongo Y, Ashida K, Ohe K, Enjoji M, Yamaguchi M, Kurata T, et al. Change of oral to topical corticosteroid therapy exacerbated glucose tolerance in a patient with plaque psoriasis. The American Journal of Case Reports. 2017;18:1198.
Hwang JL, Weiss RE. Steroid‐induced diabetes: a clinical and molecular approach to understanding and treatment. Diabetes/metabolism research and reviews. 2014;30(2):96-102.
Poetker DM, Reh DD. A comprehensive review of the adverse effects of systemic corticosteroids. Otolaryngologic Clinics of North America. 2010;43(4):753-68.
Gras MP, Verrecchia F, Uitto J, Mauviel A. Downregulation of human type VII collagen (COL7A1) promoter activity by dexamethasone: Identification of a glucocorticoid receptor binding region. Experimental dermatology. 2001;10(1):28-34.
Uva L, Miguel D, Pinheiro C, Antunes J, Cruz D, Ferreira J, et al. Mechanisms of action of topical corticosteroids in psoriasis. International journal of endocrinology. 2012;2012.
Whalen K. Lippincott® Illustrated Reviews: Pharmacology: Wolters kluwer india Pvt Ltd; 2018.
Sánchez‐Armendáriz K, García‐Gil A, Romero CA, Contreras‐Ruiz J, Karam‐Orante M, Balcazar‐Antonio D, et al. Oral vitamin D3 5000 IU/day as an adjuvant in the treatment of atopic dermatitis: a randomized control trial. International Journal of Dermatology. 2018;57(12):1516-20.
Dominguez LJ, Farruggia M, Veronese N, Barbagallo M. Vitamin D sources, metabolism, and deficiency: available compounds and guidelines for its treatment. Metabolites. 2021;11(4):255.
Borges CdS, Dias AFM, Silva PV, Rosa JL, Guerra MT, Silva RF, et al. Long-term adverse effects on reproductive function in male rats exposed prenatally to the glucocorticoid betamethasone. Toxicology. 2017;376:15-22.
Stout A, Friedly J, Standaert CJ. Systemic absorption and side effects of locally injected glucocorticoids. PM&R. 2019;11(4):409-19.
Canalis E, Giustina A, Bilezikian JP. Mechanisms of anabolic therapies for osteoporosis. New England Journal of Medicine. 2007;357(9):905-16.
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Iraqi Journal of Pharmaceutical Sciences( P-ISSN 1683 - 3597 E-ISSN 2521 - 3512)
This work is licensed under a Creative Commons Attribution 4.0 International License.
